Which has the lower trailing P/E, DGICA or DMII?

DGICA has the lower trailing P/E: DGICA trades at 9.19 and DMII at 34.76. P/E is one valuation measure and does not by itself establish which business is cheaper.

Does DGICA or DMII pay a bigger dividend?

DGICA pays a dividend (4.11% yield), while DMII has no payments in the available dividend history.

Is DGICA or DMII more profitable?

DGICA runs the higher net margin — DGICA at 7.38% versus DMII at 0.00%.

Donegal Group Inc. (DGICA) vs Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)

A side-by-side comparison of Donegal Group Inc. and Drugs Made In America Acquisition II Corp. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DGICA

Donegal Group Inc.

$670M

$18.19Financial ServicesDelayed quote: Oct 6, 2026, 4:00 PM EDT

DMII

Drugs Made In America Acquisition II Corp. Ordinary Shares

$649M

$10.19Financial ServicesDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — DGICA vs DMII

growth of $100 · dividends reinvested · last 1y

DGICA -6.5% (-6.5%/yr)DMII +3.1% (+3.1%/yr)DMII compounded faster over this window

DGICA DMII

DGICA vs DMII: by the numbers

•DGICA is the larger company ($670M vs $649M market cap).
•DGICA trades at the lower trailing earnings multiple (9.19 vs 34.76 P/E), one valuation lens rather than an overall verdict.
•DGICA is profitable (7.38% net margin) while DMII runs a net loss (0.00%).
•DGICA pays a dividend (4.11% yield), while DMII has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DGICA	DMII
P/E ratio	9.19	34.76
Forward P/E	10.11	N/A
PEG ratio	2.58	N/A
P/S ratio	0.70	N/A
P/B ratio	1.01	1.31

Profitability

Metric	DGICA	DMII
Gross margin	N/A	0.00%
Operating margin	9.10%	0.00%
Net margin	7.38%	0.00%
ROE	10.67%	2.62%
ROIC	N/A	-0.28%

Donegal Group Inc.: Gross margin is not shown for a lender or insurer: its revenue is interest, premiums and fees rather than the sale of goods, so there is no cost of goods sold to measure it against.

Dividends

Metric	DGICA	DMII
Dividend yield	4.11%	N/A
Payout ratio	37.88%	N/A

Growth (annualized)

Metric	DGICA	DMII
Revenue CAGR (5Y)	3.86%	N/A
EPS CAGR (5Y)	4.28%	N/A
Total return CAGR (5Y)	9.25%	N/A

Frequently asked

Which has the lower trailing P/E, DGICA or DMII?: DGICA has the lower trailing P/E: DGICA trades at 9.19 and DMII at 34.76. P/E is one valuation measure and does not by itself establish which business is cheaper.
Does DGICA or DMII pay a bigger dividend?: DGICA pays a dividend (4.11% yield), while DMII has no payments in the available dividend history.
Is DGICA or DMII more profitable?: DGICA runs the higher net margin — DGICA at 7.38% versus DMII at 0.00%.

Go deeper

Full DGICA analysis Full DMII analysis Interactive comparison tool

Dig into the metrics

Donegal P/E ratio Drugs Made In America Acquisition II Corp. Ordinary Shares P/E ratio Donegal dividend yield Donegal ROE Drugs Made In America Acquisition II Corp. Ordinary Shares ROE Donegal operating margin Drugs Made In America Acquisition II Corp. Ordinary Shares operating margin Donegal revenue growth Drugs Made In America Acquisition II Corp. Ordinary Shares revenue growth Drugs Made In America Acquisition II Corp. Ordinary Shares free cash flow

Donegal & Drugs Made In America Acquisition II Corp. Ordinary Shares appear in these rankings

Highest Dividend Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.